Darunavir Ethanolate/TMC-41629

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDarunavir Ethanolate/TMC-41629
Drug Alias NameTMC114/TMC41629Darunavir/TMC41629TMC-41629/Darunavir EthanolateDarunavir Ethanolate and TMC-41629Darunavir/TMC-41629
ClassificationSmall molecules
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Darunavir EthanolateTMC-41629
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative Medicine
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A